Spring direct naar de hoofdnavigatie of de inhoud

Andreas Keymer

Patent attorney

‘Intellectual property is the engine of innovation. Let’s take action!’
Andreas Keymer

Andreas Keymer

  • Life Sciences
  • Trainee Patent Attorney

Andreas Keymer studied Biology and Chemistry at the Ludwigs-Maximilians University (LMU) in Munich. He performed his graduation work at the institute of genetics and completed his studies in 2014. In 2015, Andreas Keymer started his doctoral studies at the LMU and later continued the work at the Technical University Munich (TUM).

Continue reading

During his doctoral work Andreas Keymer specialized in plant genetics with a strong focus on molecular mechanisms that regulate plant-microbe interactions. His research interest addressed the interplay of plants with beneficial as well as detrimental microbes in order to find new means for applied agriculture.

Education

  • PhD in Plant Genetics, Ludwigs-Maximilians University, Munich (2019)
  • State examination in Biology & Chemistry, Ludwigs-Maximilians University, Munich (2014)

Publications

  • Brands M, Wewer V, Keymer A, Gutjahr C, Dörmann P (2018) The Lotus japonicus acyl-acyl carrier protein thioesterase FatM is required for mycorrhiza formation and lipid accumulation of Rhizophagus irregularis. Plant Journal, DOI: 10.1111/tpj.13943.
  • Keymer A, Gutjahr C (2018) Cross kingdom lipid transfer in arbuscular mycorrhiza symbiosis and beyond. Current Opinion in Plant Biology 44: 137-144.
  • Keymer A, Huber C, Eisenreich W, Gutjahr C (2018) Tracking lipid transfer by fatty acid isotopolog profiling from host plants to arbuscular mycorrhiza fungi. Bio-protocol 8(7): e2786.
  • Keymer A, Pimprikar P, Wewer V, Huber C, Brands M, Bucerius SL, Delaux PM, Klingl V, von Roepenack-Lahaye E, Wang TL, Eisenreich W, Dörmann P, Parniske M, Gutjahr C (2017) Lipid transfer from plants to arbuscular mycorrhiza fungi. eLife 6. pii: e29107.

Languages

  • German
  • English

Also see these experts

Annemiek Tepper

Annemiek Tepper

  • European Patent Attorney
  • Dutch Patent Attorney
  • Senior Associate
Bart van Wezenbeek

Bart van Wezenbeek

  • European Patent Attorney
  • Dutch Patent Attorney
  • Of counsel
More experts

News

Knowledge sharing as keyword for optimal service provision

Sharing knowledge is not only the basic principle of the patent system – publishing the invention in exchange for the right to deter others from using it – but has also become an increasingly important driver of IP service provision.Continue reading

New Chairman of V.O.

As of 1 September, Herman Witmans will be the new Chairman of V.O. He is succeeding Cees Jansen. Cees has worked there for 26 years, of which more than 12 years as Chairman. He will remain associated with the organization as an advisor.Continue reading

The best-known medicine in the world: Aspirin

At the end of the 19th century, a young researcher from Bayer made one the most significant discoveries ever – the painkiller Aspirin. It was valuable for his employer, and also for his father who suffered from rheumatism. It led to a worldwide success!Continue reading

Events

European Patent Seminar

Hotel Excelsior München, Schützenstraße, Munich, Germany

Know the latest ins-and-outs concerning examination, opposition and appeal proceedings before the EPO. Be updated on the unitary patent and the unified patent court. Continue reading

Improve your practical knowledge at the IP Academy 2019 – Basic

Winthontlaan 6, 3526 KV Utrecht, Utrecht, Netherlands

Follow the annual course on patents, trademarks and designs. For innovative entrepreneurs who wish to improve their intellectual property (IP) know-how, V.O. Patents & Trademarks organizes a basic course on IP on Thursday 26 September. Continue reading

IPBC Asia 2019

Palace Hotel Tokyo, 1 Chome-1-1 Marunouchi, Chiyoda City, Tokyo, Japan

Returning to Tokyo, IPBC Asia 2019 is set to be the largest yet – building on the phenomenal success of the event since its launch in 2013. IPBC Asia is focused on chief IP officers, heads of intellectual property or their equivalents at major corporates from across Asia-Pacific; and their counterparts at major multinationals Continue reading